Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Bristol-Myers To Acquire Diabetes Maker Amylin For $5.3 Billion
Bloomberg
Friday, June 29, 2012 - 10:21pm
tags:
Amylin, Bristol-Myers Squibb, M&A, diabetes
Massachusetts Docs May Get Free Lunches
Pharmalot
Friday, June 29, 2012 - 12:09pm
tags:
physicians, Massachusetts, physician gifts
Vivus Shares Set To Gain From Qnexa Despite Vulnerability
Yahoo/Reuters
Friday, June 29, 2012 - 12:08pm
tags:
Vivus, Qnexa
Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Myotonic Dystrophy
Yahoo
Friday, June 29, 2012 - 12:03pm
tags:
Isis Pharmaceuticals, Biogen Idec, antisense, muscular dystrophy
Allergan Second Quarter Earnings Preview
Investopedia.com
Friday, June 29, 2012 - 12:02pm
tags:
Allergan, earnings
The $150 Million Patent
Motley Fool
Friday, June 29, 2012 - 11:59am
tags:
patents, AMR101, Amarin, GSK, Par Pharmaceutical, Teva Pharmaceuticals
Icahn suing Forest, cites succession plan worries
Reuters
Friday, June 29, 2012 - 11:56am
tags:
Forest Labs, Carl Icahn
Why A Change In A Bristol-Myers Hepatitis C Trial Has Big Implications
Forbes
Friday, June 29, 2012 - 9:25am
tags:
hepatitis C, Bristol-Myers Squibb, Gilead, NS5A Inhibitors, daclatasvir
GSK again extends its $2.6 billion Human Genome offer
Reuters
Friday, June 29, 2012 - 9:22am
tags:
GSK, Human Genome Sciences, M&A
Johnson & Johnson's $21.3 Billion Purchase Will Pay Off For Investors
Seeking Alpha
Friday, June 29, 2012 - 9:20am
tags:
JNJ, Abbott Laboratories, GSK
Obesity Drug Stocks Go Wild After Belviq Approval
Investors.com
Thursday, June 28, 2012 - 6:14pm
tags:
obesity, lorcaserin, Belviq, Arena Pharmaceuticals, Orexigen, Vivus
Gilead Submits New Drug Application to U.S. FDA for Boosting Agent Cobicistat
Yahoo
Thursday, June 28, 2012 - 6:13pm
tags:
FDA, Gilead, cobicistat
What The Supreme Court Ruling Means For Pharma
Forbes
Thursday, June 28, 2012 - 6:05pm
tags:
healthcare reform, Supreme Court
Astellas Bladder Treatment Wins U.S. Approval For Sale
Bloomberg
Thursday, June 28, 2012 - 6:04pm
tags:
Astellas, FDA, overactive bladder, mirabegron
Merck's $303 Million Ambryx Deal Great For Investors
Seeking Alpha
Thursday, June 28, 2012 - 6:03pm
tags:
Merck, Ambryx, AstraZeneca, GSK, Novartis, Pfizer, Palatin
Why ViroPharma May Be About to Take Off
Motley Fool
Thursday, June 28, 2012 - 12:53pm
tags:
ViroPharma
Vertex shares drop 11% on CF drug study
Marketwatch
Thursday, June 28, 2012 - 12:52pm
tags:
Vertex Pharmaceuticals, cystic fibrosis, VX-809
GlaxoSmithKline dips on renewed talk of interest in US group BioMarin
Guardian, UK
Thursday, June 28, 2012 - 12:49pm
tags:
GSK, Biomarin, M&A, Shire
Anthera plunges on drug study
Marketwatch
Thursday, June 28, 2012 - 12:47pm
tags:
Anthera, blisibimod, lupus
Shire Seen Luring Pfizer To Teva With Lowest Valuation: Real M&A
Bloomberg
Thursday, June 28, 2012 - 12:46pm
tags:
Shire, Pfizer, Teva Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.